Expertise at Santé publique France
Santé publique France has a mandate to provide expert advice as set forth in Ordinance No. 2016-462 of April 14, 2016: “Within its area of competence and to carry out its missions, the agency provides expert advice in accordance with the principles set forth in Article L. 1452-11. Its opinions and recommendations are issued in compliance with the provisions of Article L. 1452-22. Subject to respect for privacy and secrets protected by law, in particular the rules relating to the protection of national defense secrets, its opinions and recommendations are made public.”
What is health expertise?
Health expertise, as defined in the Charter on Health Expertise, is a set of activities aimed at informing public decision-makers and supporting their decision-making on health and public health safety.
In response to a question posed by a client (e.g., the Directorate General for Health), Santé publique France provides an opinion, an interpretation, or a recommendation—all as objectively grounded as possible—based on a critical analysis of the best available evidence and well-reasoned arguments grounded in explicit criteria, accompanied by professional judgment rooted in the experts’ experience.
The Agency’s opinions and recommendations, produced in accordance with the Charter on Health Expertise—whether through internal institutional expertise or external collegial expertise—serve as decision-making aids for public authorities.
The decision on how to act on the Agency’s opinions and recommendations rests with the commissioning party that submitted the inquiry.
Note: Activities aimed at generating new knowledge—whether through the collection of new data or the secondary analysis of existing data—do not fall under the scope of health expertise as defined by the Charter.
What are the principles of health expertise?
The charter on health expertise defines its principles: impartiality, transparency, plurality, and the adversarial process. It also specifies the procedures for its implementation, particularly the selection of stakeholders in health expertise, the health expertise process and its relationship to decision-making, the concept of conflicts of interest, and how they are managed.
Santé publique France has developed its expert review process in accordance with the Charter on Health Expertise. This document presents the key principles and provides an operational description of the steps and procedures involved in the health expertise process at the agency. Health expertise at Santé publique France is conducted either through internal institutional expertise, provided by its staff and regular partners, or through external collegial expertise provided by committees of experts.
The Scientific Council of Santé publique France first reviews whether it is appropriate to establish an expert committee within the agency. The expert committees report to the agency’s directorates, which provide scientific coordination and administrative support.
Participation in National Expert Groups
Santé publique France contributes to expert work on public health and health safety at the national level. Staff members contribute by serving as members of committees, commissions, or expert groups, or by testifying as part of the process of developing opinions and recommendations. They contribute either in their own capacity, based on their scientific and technical expertise, or on behalf of the agency to represent it, in accordance with the specific rules and operating procedures of each of these expert bodies. These various contributions reflect recognition of the agency’s scientific and operational contribution to this work.
At the national level, Santé publique France is an ex officio member of the five commissions of the High Council for Public Health (HCSP). The agency is also an ex officio member of the Technical Commission on Vaccinations (CTV) and the CTV Executive Committee of the High Authority for Health (HAS), with an advisory role: in this context, the agency may be called upon to provide or present epidemiological data necessary for the work of this commission.
Staff members of Santé publique France have contributed to the following French expert reports and evaluations (in alphabetical order):
- the National Agency for Food, Environmental and Occupational Health & Safety (ANSES): 39 deliverables in 2025;
- the National Council on AIDS and Hepatitis (CNS): 2 deliverables in 2025 (including one jointly with ANRS-MIE and HAS);
- the High Council for Public Health (HCSP): 14 deliverables in 2025;
- the High Authority for Health (HAS): 19 deliverables in 2025.
Opinions and recommendations issued by Santé publique France
Decision-Support Notes (internal expert assessment)
- Start date of the next immunization campaign for newborns against RSV bronchiolitis for the 2026–2027 season (mainland France and overseas departments and regions) (2026)
- Analysis of the epidemiological impact of different vaccination strategies on the incidence of pediatric tuberculosis: arguments in favor of a possible change to the current BCG vaccination strategy in mainland France (2026)
- Current Status and Proposals for Updating Santé publique France’s Surveillance and Prevention Systems in the Context of Implementing the Future National Plan for Preparedness and Management of Extreme Temperatures (2026)
- Analysis of the relevance and feasibility of monitoring the health status of French populations potentially exposed or overexposed to PFAS (2026)
- Start date of the next immunization campaign for newborns against RSV bronchiolitis for the 2025–2026 season (mainland France and overseas departments and regions). Agency’s interpretation and recommendation (2025)
- Decision-support note. Assessment of the epidemiological situation of Respiratory Syncytial Virus (RSV) among infants under 2 years of age in French Guiana with a view to potential changes in the regional strategy for immunizing newborns and vaccinating pregnant women against this virus (2025)
Confidential National Survey on Maternal Deaths and Expert Committee on Maternal Mortality (in progress)
- Report of the National Expert Committee on Maternal Mortality (CNEMM)
- More information on the Confidential Survey on Maternal Deaths
Expert Committee on Health, Environment, and Work (ongoing)
- Opinion regarding the responses Santé publique France can provide to public health challenges in the context of local investigations into health, environment, and work. Opinion based on the conclusions and recommendations of the Expert Committee on Health, Environment, and Work (2026)
- Opinion of Santé publique France regarding studies conducted in the Orbiel Valley, following the opinion of the Health, Environment, and Occupational Health Expert Committee (2026)
- Joint opinion of Santé publique France and the National Agency for Food, Environmental and Occupational Health & Safety regarding the PestiRiv study, a study of pesticide exposure among residents living near wine-growing and non-wine-growing areas (2025)
- Agency opinion regarding the follow-up to the REVELA 13 observatory following the opinion of the Health, Environment, and Occupational Safety Expert Committee (2024)
Ad Hoc Expert Committees (closed)
- Expert opinion on shifts in public discourse regarding alcohol consumption in France, organized by Santé publique France and the National Cancer Institute (2017)
- Expert opinion on the strategy for establishing a stockpile of medical countermeasures in the event of an influenza pandemic (2019)
Expert Committee on Prevention and Health Promotion (concluded)
- Expert opinion on obesity prevention in the context of social inequalities in health (2024)
- Expert opinion on the implementation of a process to analyze the effectiveness of interventions as part of the creation of a portal for evidence-based interventions in prevention and health promotion (2019)
Expert Committee on “Transverse Ageneisies of the Limbs” (closed)
- Supplement to the report of the Scientific Expert Committee on Transverse Agenesis of the Upper Limbs (ATMS), published on July 11, 2019. Referral No. 2018-SA-0242 “Request for an opinion regarding the existence of clustered cases of transverse agenesis of the upper limbs in specific geographic areas of three departments (Ain, Morbihan, and Loire-Atlantique).” Report of the Committee of Scientific Experts (2022)
- First Report on Transverse Agenesia of the Upper Limbs (ATMS). Case No. 2018-SA-0242 “Request for an opinion regarding the existence of clustered cases of transverse agenesis of the upper limbs in specific geographic areas of three departments (Ain, Morbihan, and Loire-Atlantique).” Report of the Committee of Scientific Experts. July 11, 2019 (updated in 2021)
1 Public Health Code. Art. L.1452-1 (accessed April 18, 2017).
2 Public Health Code. Art. L.1452-2 (accessed April 18, 2017).
3 Decree No. 2013-413 of May 21, 2013, approving the charter for health assessments provided for in Article L.1452-2 of the Public Health Code (accessed April 18, 2017).